Last update :
19/11/2024
Anticoagulant   Dalteparin sodium  
injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References pdf

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Dalpin India
Daltehep India
Daltepin India
Fragmin Australia, Austria, Belgium, Canada, Chile, Colombia, Denmark, Ecuador, Egypt, Finland, Germany, Great Britain, Greece, Hungary, Iceland, India, Iran, Italy, Malaysia, Mexico, Netherlands, New Zealand, Norway, Poland, Portugal, Romania, Spain, Sweden, Switzerland, Tunisia, Turkey, United Arab Emirates, United States of America, Venezuela
Fragmine France
References   injection   References : Dalteparin sodium  
Type Publication
1624 Journal Louie S, Chin A, Gill MA.
Activity of dalteparin sodium in polypropylene syringes.
Am J Health-Syst Pharm 2000 ; 57: 760-762.
1873 Journal Laposata M, Johnson SM.
Assessment of the stability of dalteparin sodium in prepared syringes for up to thirty days/ In vitro study.
Clin Ther 2003 ; 25: 1219-1224.
2268 Journal Goldenberg NA, Jacobson L, Hthaway H, Tripputi M, Primeaux J, Child J.
AntiXa stability of diluted dalteparin for pediatric use.
Ann Pharmacotherapy 2008 ; 42, 4: 511-515.
3643 Manufacturer Gentamicin sulphate (Cidomycin®) - Summary of Product Characteristics
Sanofi 2015
4031 Journal Kirkham K, Munson J, McCluskey S, Graner K.
Stability of Dalteparin 1,000 Unit/mL in 0.9% Sodium Chloride for Injection in Polypropylene Syringes.
Int J Pharm Compound 2017 ;21 , 5 : 426-429

  Mentions Légales